Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Oric Pharmaceuticals, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 182
- +18 vs. Q4 2025
- Shares held
- 119.4M
- +4.25M (+3.7%) vs. Q4 2025
- Total value
- $1.51B
- +$567.4M (+60.2%) vs. Q4 2025
- New holders
- 40
- 57 more added
- Sold out
- 22
- 64 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 180 | $1.34B |
| Q1 2026 | 182 | $1.51B |
| Q4 2025 | 165 | $979.6M |
| Q3 2025 | 152 | $1.28B |
| Q2 2025 | 142 | $947.6M |
| Q1 2025 | 143 | $442.0M |
| Q4 2024 | 129 | $611.7M |
| Q3 2024 | 122 | $715.1M |
| Q2 2024 | 113 | $478.3M |
| Q1 2024 | 112 | $879.3M |
| Q4 2023 | 92 | $465.9M |
| Q3 2023 | 90 | $290.7M |
| Q2 2023 | 83 | $353.4M |
| Q1 2023 | 71 | $188.5M |
| Q4 2022 | 64 | $192.1M |
| Q3 2022 | 76 | $104.6M |
| Q2 2022 | 83 | $147.1M |
| Q1 2022 | 101 | $181.7M |
| Q4 2021 | 80 | $512.1M |
| Q3 2021 | 82 | $762.1M |
| Q2 2021 | 78 | $639.4M |
| Q1 2021 | 82 | $874.3M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Oric Pharmaceuticals, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Boothbay Fund Management, LLC | 61,957 | $785.0K | 0.02% | −156,653−71.7% | Reduced |
| DAFNA Capital Management LLC | 98,724 | $945.5K | 0.22% | −42,321−30.0% | Reduced |
| Rhumbline Advisers | 79,063 | $1.00M | 0.00% | +1,357+1.7% | Added |
| Swiss National Bank | 86,200 | $1.09M | 0.00% | 00.0% | Unchanged |
| Abu Dhabi Investment Council Co P.J.S.C | 89,441 | $1.13M | 0.12% | +89,441 | New |
| Prudential Financial Inc | 96,145 | $1.22M | 0.00% | +96,145 | New |
| Ishara Investments LP | 102,500 | $1.30M | 1.31% | −57,500−35.9% | Reduced |
| Invesco Ltd. | 108,954 | $1.38M | 0.00% | −788−0.7% | Reduced |
| Y-Intercept (Hong Kong) Ltd | 111,992 | $1.42M | 0.03% | −229,431−67.2% | Reduced |
| Superstring Capital Management LP | 115,234 | $1.46M | 1.04% | −140,136−54.9% | Reduced |
| Rafferty Asset Management, LLC | 115,480 | $1.46M | 0.01% | −61,699−34.8% | Reduced |
| Algert Global LLC | 136,350 | $1.73M | 0.03% | +95,840+236.6% | Added |
| Alyeska Investment Group, L.P. | 137,489 | $1.74M | 0.00% | +137,489 | New |
| American Century Companies Inc | 146,804 | $1.86M | 0.00% | +11,874+8.8% | Added |
| Blue Owl Capital Holdings LP | 150,000 | $1.90M | 0.51% | −365,000−70.9% | Reduced |
| Nuveen, LLC | 153,022 | $1.94M | 0.00% | +8,619+6.0% | Added |
| Hennion & Walsh Asset Management, Inc. | 160,054 | $2.03M | 0.07% | −10,018−5.9% | Reduced |
| AQR Capital Management LLC | 170,087 | $2.16M | 0.00% | −4,192−2.4% | Reduced |
| Boxer Capital Management, LLC | 176,500 | $2.24M | 0.29% | +176,500 | New |
| Manufacturers Life Insurance Company, The | 182,139 | $2.31M | 0.00% | +53,490+41.6% | Added |
| Wellington Management Group LLP | 186,099 | $2.36M | 0.00% | −5,724−3.0% | Reduced |
| ExodusPoint Capital Management, LP | 186,145 | $2.36M | 0.02% | +77,310+71.0% | Added |
| Bank of New York Mellon Corp | 190,470 | $2.41M | 0.00% | +2,549+1.4% | Added |
| UBS Group AG | 194,689 | $2.47M | 0.00% | −540,169−73.5% | Reduced |
| Atom Investors LP | 226,804 | $2.87M | 0.21% | −63,158−21.8% | Reduced |
| TD Asset Management Inc | 258,602 | $3.28M | 0.00% | +88,772+52.3% | Added |
| Russell Investments Group, Ltd. | 263,059 | $3.33M | 0.00% | +56,022+27.1% | Added |
| JPMorgan Chase & Co | 323,584 | $3.94M | 0.00% | −91,202−22.0% | Reduced |
| Adage Capital Partners GP, L.L.C. | 344,315 | $4.36M | 0.01% | −204,685−37.3% | Reduced |
| Victory Capital Management Inc | 405,280 | $5.13M | 0.00% | +72,520+21.8% | Added |
| Redmile Group, LLC | 415,710 | $5.27M | 0.35% | −32,400−7.2% | Reduced |
| Vanguard Fiduciary Trust Co | 507,294 | $6.43M | 0.00% | +507,294 | New |
| Connor, Clark & Lunn Investment Management Ltd. | 522,061 | $6.61M | 0.02% | +171,177+48.8% | Added |
| NEXTBio Capital Management LP | 523,619 | $6.63M | 3.08% | −92,101−15.0% | Reduced |
| Balyasny Asset Management LLC | 523,790 | $6.64M | 0.01% | −426,424−44.9% | Reduced |
| Sphera Funds Management Ltd. | 537,628 | $6.81M | 1.17% | −466,750−46.5% | Reduced |
| Polar Capital Holdings Plc | 539,377 | $6.83M | 0.03% | +37,013+7.4% | Added |
| Lord, Abbett & Co. LLC | 542,598 | $6.88M | 0.02% | −21,655−3.8% | Reduced |
| Vanguard Portfolio Management LLC | 570,691 | $7.23M | 0.00% | +570,691 | New |
| Candriam Luxembourg S.C.A. | 574,085 | $7.27M | 0.04% | +574,085 | New |
| Charles Schwab Investment Management Inc | 605,037 | $7.67M | 0.00% | −16,049−2.6% | Reduced |
| Sofinnova Investments, Inc. | 679,578 | $8.61M | 0.43% | +679,578 | New |
| Northern Trust Corp | 710,861 | $9.01M | 0.00% | −174,614−19.7% | Reduced |
| Defilade Capital Management, L.P. | 842,928 | $10.7M | 1.50% | +842,928 | New |
| Qube Research & Technologies Ltd | 859,491 | $10.9M | 0.02% | −345,938−28.7% | Reduced |
| Logos Global Management LP | 950,000 | $12.0M | 0.62% | +500,000+111.1% | Added |
| Eventide Asset Management, LLC | 953,451 | $12.1M | 0.20% | +1,080+0.1% | Added |
| ArrowMark Colorado Holdings LLC | 960,517 | $12.2M | 0.32% | −103,252−9.7% | Reduced |
| Euclidean Capital LLC | 989,410 | $12.5M | 3.20% | 00.0% | Unchanged |
| Bank of America Corp | 1,043,159 | $13.2M | 0.00% | +535,649+105.5% | Added |
| Silverarc Capital Management, LLC | 1,100,010 | $13.9M | 1.64% | −16,594−1.5% | Reduced |
| Braidwell LP | 1,128,040 | $14.3M | 0.48% | +1,128,040 | New |
| Royce & Associates LP | 1,207,223 | $15.3M | 0.15% | −300,078−19.9% | Reduced |
| Woodline Partners LP | 1,247,515 | $15.8M | 0.06% | +1,000,981+406.0% | Added |
| Integral Health Asset Management, LLC | 1,400,000 | $17.7M | 0.94% | +200,000+16.7% | Added |
| Franklin Resources Inc | 1,452,835 | $18.4M | 0.00% | +240,288+19.8% | Added |
| Dimensional Fund Advisors LP | 1,471,290 | $18.6M | 0.00% | +244,060+19.9% | Added |
| Goldman Sachs Group Inc | 1,475,712 | $18.7M | 0.00% | −463,573−23.9% | Reduced |
| Morgan Stanley | 1,682,523 | $21.3M | 0.00% | +488,450+40.9% | Added |
| Paradigm Biocapital Advisors LP | 1,701,217 | $21.6M | 0.44% | −700,000−29.2% | Reduced |
| MPM Oncology Impact Management LP | 1,803,945 | $22.9M | 1.77% | +5,228+0.3% | Added |
| Geode Capital Management, LLC | 1,838,801 | $23.3M | 0.00% | +88,107+5.0% | Added |
| Vivo Capital, LLC | 1,848,786 | $23.4M | 1.95% | −269,598−12.7% | Reduced |
| First Turn Management, LLC | 2,017,284 | $25.6M | 2.86% | +6,977+0.3% | Added |
| Citadel Advisors LLC | 2,422,741 | $30.7M | 0.02% | −11,969−0.5% | Reduced |
| FMR LLC | 2,434,080 | $30.8M | 0.00% | −44,842−1.8% | Reduced |
| AIHC Capital Management Ltd | 2,459,551 | $31.2M | 26.04% | +2,459,551 | New |
| OrbiMed Advisors LLC | 2,693,929 | $34.1M | 0.78% | −947,827−26.0% | Reduced |
| Siren, L.L.C. | 2,998,192 | $38.0M | 1.05% | +1,990,617+197.6% | Added |
| The Column Group LLC | 3,540,777 | $44.9M | 44.55% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 3,687,007 | $46.7M | 0.00% | +3,687,007 | New |
| State Street Corp | 3,702,196 | $46.9M | 0.00% | −556,201−13.1% | Reduced |
| NEA Management Company, LLC | 4,118,621 | $52.2M | 2.97% | 00.0% | Unchanged |
| VR Adviser, LLC | 4,319,765 | $54.7M | 2.04% | −1,356,465−23.9% | Reduced |
| Alkeon Capital Management LLC | 4,504,096 | $57.1M | 0.26% | 00.0% | Unchanged |
| Pfizer Inc | 4,780,401 | $57.7M | 24.14% | −595,943−11.1% | Reduced |
| Sr One Capital Management, LP | 4,514,929 | $58.5M | 6.39% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 5,387,783 | $68.3M | 0.01% | +2,092,661+63.5% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 5,824,533 | $73.8M | 0.21% | −748,158−11.4% | Reduced |
| BlackRock, Inc. | 5,984,552 | $75.8M | 0.00% | +109,499+1.9% | Added |
| EcoR1 Capital, LLC | 6,728,116 | $85.2M | 3.64% | 00.0% | Unchanged |
| Nextech Invest, Ltd. | 7,162,637 | $90.8M | 6.39% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −2,923,077−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −572,724−100.0% | Sold out |
| Kalehua Capital Management LLC | 0 | $0 | 0.00% | −267,059−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −229,383−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −44,387−100.0% | Sold out |
| VARCOV Co. | 0 | $0 | 0.00% | −32,036−100.0% | Sold out |
| NEOS Investment Management LLC | 0 | $0 | 0.00% | −28,269−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −25,518−100.0% | Sold out |
| Freestone Grove Partners LP | 0 | $0 | 0.00% | −24,207−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −22,799−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −19,638−100.0% | Sold out |
| DRW Securities, LLC | 0 | $0 | 0.00% | −19,194−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −14,349−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −12,512−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −11,533−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −10,366−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −10,335−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −9,706−100.0% | Sold out |